A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

NCT01739647 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Young Volunteers
Healthy Elderly Volunteers

Interventions

DRUG: AZD3293
DRUG: Placebo

Sponsor

AstraZeneca